Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIP0612 in Gastric Ulcer
NCT05656092Phase 3Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Mar 2023
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
A Phase 3 trial of HIP0612 in gastric ulcer, sponsored by Hanmi Pharmaceutical. Started Mar 2023; status: completed.
02
Drugs
HIP0612
03
Conditions
gastric ulcer
Beyond the preview
Go deeper on NCT05656092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05656092.